CGON

Neutral

CG Oncology (CGON) Expected to Announce Quarterly Earnings on Thursday

CG Oncology (CGON) is expected to report its Q1 2026 earnings before market open on Thursday, May 7th, with analysts forecasting ($0.58) EPS and $0.45...

MarketBeat 1 week ago 0

Bullish

CG Oncology (CGON) Is Up 6.8% After Naming Biotech Veteran Jim DeTore CFO - Has The Bull Case Changed?

CG Oncology has appointed biotech veteran Jim DeTore as Chief Financial Officer, following his successful interim tenure and prior experience at other...

Simply Wall Street 2 weeks ago 0